Laquinimod Combination Therapy For Treatment Of Multiple Sclerosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170304253A1
SERIAL NO

15643214

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA PHARMACEUTICAL INDUSTRIES LTDTEL AVIV 6944020

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kaye, Joel Netanya, IL 33 203
Knappertz, Volker Potomac, US 42 409

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation